Where to focus in 2025
A new record for gene therapy
With more than 280 therapies in Phase 1-3 of development, gene therapy has the potential to transform healthcare by possibly preventing or curing chronic diseases.
The recent approval of a $4.25 million gene therapy for a rare neurological disorder underscores the escalating costs of advanced treatments, highlighting the urgent need for a sustainable financial model in healthcare.
0.00
%
Projected overall drug price inflation rate for Jan. 1, 2025 – Dec. 31, 2025
Access now
Empower your decision-making with our latest projections and insights
The summer 2024 Pharmacy Market Outlook represents our best estimate of the change in the price of pharmaceuticals that Vizient pharmacy program participants will purchase between Jan. 1, 2025 and Dec. 31, 2025.
Pharmacy program participants
Enjoy access to companion resources and additional information
A high-level overview and highlights from the Pharmacy Market Outlook.
Read the executive summaryIncludes an overview of the strategic importance of the pharmacy enterprise, the power (and price) of gene therapy and a pharmacy enterprise preparedness assessment.
Read and share the letter to the C-suiteAnticipated high-impact approvals — Overview of anticipated high-impact approvals over the next year listed by therapeutic area. Includes drug indications and estimated wholesale acquisition costs.
New and noteworthy novel drug approvals — Forecasted timeline for new drug approvals, including route, MOA, indication(s) and noteworthy information.
Summaries from key therapeutic classes including autoimmune and inflammatory diseases, biosimilars, endocrine and metabolic diseases, infectious diseases, oncology, pediatrics, plasma and more. Includes top spend drugs, projected inflation rates and trends for each therapeutic area.
Access nowAdvocacy in action — Numerous aspects of pharmaceutical policy and pharmacy practice remain the subject of existing bills, laws and regulations regarding safety, quality, and of course, cost. Read about some of the most critical policy issues covered in the second half of 2024, as well as areas requiring attention from pharmacy leaders in the near term.
Access the Drug Budget Forecast Report and apply the projections in the Pharmacy Market Outlook to your unique purchasing patterns to develop your plan for 2025. This tool is available through Vizient Pharmacy Analytics, accessible through the Pharmacy Portal from your Dashboard. Available July 31.
Find out how to use the report — This guide provides an overview on how to best utilize and optimize the Drug Budget Forecast reporting solution. Available July 31.
Launch webinar recording and presentation.
Financial leaders recording and presentation.
High-impact pipeline: products and services recording and presentation.
Taking a BiTE out of CAR-T recording and presentation
Register now for the Spend Management Outlook launch webinar
Wednesday, Jan. 29, 2025
1-2 p.m. CT
Join us for the launch of the winter 2025 Spend Management Outlook when we will review the insights and projections provided in the inaugural edition of the report.
Derived from the unique expertise and analytics from across the Spend Management team, this resource combines and expands on the predictive capabilities from our Budget Impact Projections report and Pharmacy Market Outlook. This report examines total expense management, including medical-surgical, laboratory, indirect spend, capital equipment, pharmacy and physician preference items in an integrated way.